Interestingly, variants of DHX34 unable to facilitate UPF1 phosphorylation have been found as pathogenic versions specific to inherited forms of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) (Rio-Machin et al., 2020). Here, DHX34 is linked to acute myeloid leukemia.